Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100047/S238

Heart Ware Ventricular Assist System (HVAD)

Medtronic · Decision date May 14, 2026

FDA DECISIONP100047/S238

What did the FDA decide?

FDA records P100047/S238 as a supplement to PMA P100047, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 14, 2026.

FDA approval order statement

addition of an alternate component for an integrated circuit on the HVAD controller
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
May 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P100047/S238
Regulatory pathway
PMA supplement
Applicant
Medtronic
Product code
DSQ
Decision code
OK30
Decision date
May 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Applicant
Medtronic
Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P100047. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P100047 · Original PMA

    HEARTWARE VENTRICULAR ASSIST SYSTEM

  2. P100047/S223 · Related supplement

    HEARTWARE VENTRICULAR ASSIST SYSTEM

  3. P100047/S238 received

    Application receipt date recorded by FDA.

  4. P100047/S238 · FDA decision

    30-Day Notice

  5. P100047/S239 · Related supplement

    HeartWare Ventricular Assist System

Timeline entries are records held by MedtechLedger for P100047. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100047

Product / regulatory recordCompanyPathwayDecision dateSource
MedtronicPMA approvalNov 20, 2012FDA
MedtronicPMA supplementFeb 3, 2026FDA
MedtronicPMA supplementFeb 18, 2026FDA
MedtronicPMA supplementApr 7, 2026FDA
MedtronicPMA supplementApr 10, 2026FDA
MedtronicPMA supplementJul 28, 2026FDA
MedtronicPMA supplementAug 5, 2026FDA
MedtronicPMA supplementSep 23, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA
AbbottPMA supplementOct 30, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records